The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study

The Lancet Oncology

Fecha de publicación: 20 July 2020

DOI: https://doi.org/10.1016/S1470-2045(20)30388-0

Autores: Camille Maringe, PhD., Prof James Spicer, PhD., Melanie Morris, PhD., Prof Arnie Purushotham, MD., Prof Ellen Nolte, PhD., Prof Richard Sullivan, PhD., et al.

Background: Since a national lockdown was introduced across the UK in March, 2020, in response to the COVID-19 pandemic, cancer screening has been suspended, routine diagnostic work deferred, and only urgent symptomatic cases prioritised for diagnostic intervention. In this study, we estimated the impact of delays in diagnosis on cancer survival outcomes in four major tumour types.